Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EPLERENONE
- Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease
- Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
- Patiromer Trial in CKD Stage IIIB to V
- Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers
- Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
- Stratified Medicine of Eplerenone in Acute MI/Injury (StratMed-MINOCA)
- Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial
- Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
- MR Antagonist and LSD1
- Effect of Eplerenone on Novel Biomarkers of Mineralocorticoid Receptor Activation (ENOVA)
- Spironolactone In The Treatment of Heart Failure
- Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
- Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
- Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
- The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.
- Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists)
- Tissue K+ in Primary Hyperaldosteronism
- Calcium Channel Blockade in Primary Aldosteronism
- RELieving Increasing oEdema Due to Heart Failure
- Non Invasive Assessment of Heart Failure
- A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
- Pressure Assessment to Improve Outcomes After TAVR: a Registry
- A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose Administration
- MR Antagonist and STRIATIN
- Spironolactone Versus Indapamide in Obese and Hypertensive Patients
- Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients
- Eplerenone as a Supplement to Epidural Steroid Injections
- Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
- This International Study Tests BI 690517 in Patients With Diabetic Kidney Disease. The Study Tests How 3 Different Doses of BI 690517 Are Taken up in the Body and How Well They Are Tolerated
- Photodynamic Therapy Versus Eplerenone: Treatment Trial for Chronic Central Serous Chorioretinopathy
- The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes
- NATIENS: Optimal Management and Mechanisms of SJS/TEN
- Pharmacokinetics Study of Eplerenone Coated Tablets
- Study of CS-3150 in Patients With Essential Hypertension
- The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production
- Mineralocorticoid Receptor Antagonists in Type 2 Diabetes
- Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)
- Cardiometabolic Effects of Eplerenone in HIV Infection
- Pharmacokinetics of Eplerenone Tablet
- Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
- Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance
- A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects
- Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
- Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
- Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
- Eplerenone Treatment for Chronic Central Serous Chorioretinopathy in Hungarian Population
- Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
- Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
- Comparison of Single and Combination Diuretics in Low-Renin Hypertension
- Eplerenone in the Management of Abdominal Aortic Aneurysms
- A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
- A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
- Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy
- The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium
- Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.
- Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism
- Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.
- The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
- Eplerenone for the Treatment of Central Serous Chorioretinopathy
- The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
- Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Diseas
- Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
- Aldosterone Antagonism and Microvascular Function
- Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
- PHOspholamban RElated CArdiomyopathy STudy - Intervention
- Eplerenone and Extracellular Adenosine Formation
- EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety
- The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)
- Eplerenone for Central Serous Chorioretinopathy
- Phase IIb Safety and Efficacy Study of Different Oral Doses of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Chroni
- Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects
- Detection of Diffuse Scar in Patients With Diabetes
- Effect of Eplerenone on Postprandial Inflammatory Response in Healthy Adults
- Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
- Eplerenone in Hemodialysis Trial
- Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes
- Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy
- Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology
- Study to Investigate the Natriuretic Effects, Safety, Tolerability and Pharmacokinetics of BAY94-8862
- A Study of LY2623091 in Male and Females With Chronic Kidney Disease
- Eplerenone in HIV Associated Abdominal Fat Accumulation
- Hypoglycemia and the Mineralocorticoid Receptor
- LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension
- Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
- Effect of Eplerenone in Elderly Hypertensive Early Stage Chronic Kidney Disease (CKD) Patients
- CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression
- Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance
- Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
- Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics
- Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
- Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function
- Aldosterone Blockade Early After Acute Myocardial Infarction
- Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity
- Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension
- Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions
- Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions
- A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives
- A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension
- A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
- If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure
- Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
- Eplerenone in Systemic Right Ventricle
- A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension
- EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion
- Defining Strategies for Improving Endothelial and Fibrinolytic Dysfunction in Obesity
- Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
- Diurnal Variation of Plasminogen Activator Inhibitor-1
- The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure
- Inhibition of Aldosterone in Patients With Chronic Renal Disease
- Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
- CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone
- Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
- Eplerenone, ACE Inhibition and Albuminuria
- Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure
- Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
- A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines
- Treatment of Supine Hypertension in Autonomic Failure
- Aldosterone and Vascular Disease in Diabetes Mellitus
- EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
- The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years
- A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.
- Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT
- Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension
- Effects of Eplerenone on Left Ventricular Remodelling Following Heart Attack
- Aldosterone Antagonism in Diastolic Heart Failure
- Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
- The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure
Clinical trials list
click for details